Figure 2

Significantly enriched DEG pathways among the three treatment groups. (A) Jejunum samples from the chlortetracycline vs. control groups. (B) Jejunum samples from the L. reuteri vs. control groups.

Significantly enriched DEG pathways among the three treatment groups. (A) Jejunum samples from the chlortetracycline vs. control groups. (B) Jejunum samples from the L. reuteri vs. control groups.